Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis (West Japan Oncolgy Group 6711L): A Phase II Study

Takekazu Iwata; Ichiro Yoshino; Shigetoshi Yoshida; Norihiko Ikeda; Masahiro Tsuboi; Yuji Asato; Nobuyuki Katakami; Yoshinori Yamashita; Kazuhiro Sakamoto; Arata Azuma; Tae Iwasawa; Kazuyoshi Kuwano; Shuji Sakai; Kenzo Hiroshima; Junya Fukuoka; Kenichi Yoshimura; Hirohito Tada; Kazuhiko Nakagawa; Yoichi Nakanishi

doi:10.1378/chest.2228629

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis (West Japan Oncolgy Group 6711L): A Phase II Study

CHEST Journal ◽

10.1378/chest.2228629 ◽

2015 ◽

Vol 148 (4) ◽

pp. 395A ◽

Cited By ~ 1

Author(s):

Takekazu Iwata ◽

Ichiro Yoshino ◽

Shigetoshi Yoshida ◽

Norihiko Ikeda ◽

Masahiro Tsuboi ◽

...

Keyword(s):

Lung Cancer ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Lung Cancer Patients

Download Full-text

OA12.03 Percutaneous Cryoablation for Lung Cancer Patients for Whom Surgery or Radiotherapy is Contraindicated Due to Idiopathic Pulmonary Fibrosis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.296 ◽

2017 ◽

Vol 12 (1) ◽

pp. S290

Author(s):

Takashi Ohtsuka ◽

Keisuke Asakura ◽

Kyohei Masai ◽

Kaoru Kaseda ◽

Ikuo Kamiyama ◽

...

Keyword(s):

Lung Cancer ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Cancer Patients ◽

Lung Cancer Patients ◽

Percutaneous Cryoablation

Download Full-text

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2016.05.094 ◽

2016 ◽

Vol 102 (6) ◽

pp. 1905-1910 ◽

Cited By ~ 33

Author(s):

Takekazu Iwata ◽

Shigetoshi Yoshida ◽

Taiki Fujiwara ◽

Hironobu Wada ◽

Takahiro Nakajima ◽

...

Keyword(s):

Lung Cancer ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Cancer Patients ◽

Lung Cancer Patients

Download Full-text

A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease

Annals of Oncology ◽

10.1093/annonc/mdy292.060 ◽

2018 ◽

Vol 29 ◽

pp. viii519-viii520 ◽

Cited By ~ 2

Author(s):

Y. Usui ◽

H. Kenmotsu ◽

K. Mori ◽

A. Ono ◽

K. Yoh ◽

...

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

A phase II study of 18F-fluorodeoxyglucose PET–CT in non-small cell lung cancer patients receiving erlotinib (Tarceva®); objective and symptomatic responses at 6 and 12weeks

European Journal of Cancer ◽

10.1016/j.ejca.2011.10.033 ◽

2012 ◽

Vol 48 (1) ◽

pp. 68-74 ◽

Cited By ~ 19

Author(s):

M.E.R. O’Brien ◽

J.S. Myerson ◽

J.I.G. Coward ◽

M. Puglisi ◽

L. Trani ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Pet Ct ◽

Fluorodeoxyglucose Pet

Download Full-text

Results of a phase II study of single-agent sunitinib in elderly non-small cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7549 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7549-7549 ◽

Cited By ~ 3

Author(s):

C. Reynolds ◽

A. I. Spira ◽

W. L. Gluck ◽

R. E. Pluenneke ◽

K. A. Boehm ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)

Respiratory Research ◽

10.1186/s12931-016-0398-4 ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 48

Author(s):

Takekazu Iwata ◽

◽

Ichiro Yoshino ◽

Shigetoshi Yoshida ◽

Norihiko Ikeda ◽

...

Keyword(s):

Lung Cancer ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Cancer Patients ◽

Acute Exacerbation ◽

Pulmonary Resection ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Oncology Group ◽

Lung Cancer Patients

Download Full-text

A multicenter prospective observational study of the safety and prognosis of lung cancer patients with idiopathic pulmonary fibrosis following surgery: Niigata Chest Surgery Study Group

The Journal of the Japanese Association for Chest Surgery ◽

10.2995/jacsurg.32.782 ◽

2018 ◽

Vol 32 (7) ◽

pp. 782-791

Author(s):

Tatsuya Goto ◽

Akihiko Kitahara ◽

Seijiro Sato ◽

Terumoto Koike ◽

Akira Okada ◽

...

Keyword(s):

Lung Cancer ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Observational Study ◽

Cancer Patients ◽

Prospective Observational Study ◽

Study Group ◽

Lung Cancer Patients ◽

Chest Surgery ◽

Multicenter Prospective Observational Study

Download Full-text

CADM1 and SPC25 gene mutations in lung cancer patients with idiopathic pulmonary fibrosis

JTO Clinical and Research Reports ◽

10.1016/j.jtocrr.2021.100232 ◽

2021 ◽

pp. 100232

Author(s):

Aya Fukuizumi ◽

Rintaro Noro ◽

Masahiro Seike ◽

Akihiko Miyanaga ◽

Yuji Minegishi ◽

...

Keyword(s):

Lung Cancer ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Cancer Patients ◽

Gene Mutations ◽

Lung Cancer Patients

Download Full-text

Phase II study of erlotinib in advanced non-small cell lung cancer patients with leptomeningeal metastasis.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20596 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20596-e20596

Author(s):

Kaname Nosaki ◽

Yoshimasa Shiraishi ◽

Fumihiko Hirai ◽

Taishi Harada ◽

Daisuke Himeji ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Leptomeningeal Metastasis ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

CarVin versus CarEto - A randomised phase II study of carboplatin and vinorelbine versus carboplatin and etoposide in good performance status small cell lung cancer patients presenting with adverse prognostic factors

http://isrctn.org/> ◽

10.1186/isrctn44486227 ◽

2012 ◽

Author(s):

Ernie Marshall

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Performance Status ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text